1.90
+0(+0.00%)
Currency In USD
| Previous Close | 1.9 |
| Open | 1.87 |
| Day High | 2.09 |
| Day Low | 1.85 |
| 52-Week High | 11.5 |
| 52-Week Low | 1.61 |
| Volume | 262,980 |
| Average Volume | 845,814 |
| Market Cap | 3.11M |
| PE | -1.28 |
| EPS | -1.48 |
| Moving Average 50 Days | 3.03 |
| Moving Average 200 Days | 3.61 |
| Change | 0 |
If you invested $1000 in Qualigen Therapeutics, Inc. (QLGN) 10 years ago, it would be worth $0 as of August 18, 2025 at a share price of $1.9. Whereas If you bought $1000 worth of Qualigen Therapeutics, Inc. (QLGN) shares 5 years ago, it would be worth $0.68 as of August 18, 2025 at a share price of $1.9.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
GlobeNewswire Inc.
Jul 28, 2025 9:20 PM GMT
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Com
Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock
GlobeNewswire Inc.
Jul 28, 2025 4:41 PM GMT
Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on developing platform treatments for adult and pediatric cancers with the potential for orphan
Qualigen Granted New Patents Covering 25 Countries
GlobeNewswire Inc.
Jul 16, 2025 12:00 PM GMT
CARLSBAD, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company” or “Qualigen”) is announcing an update on patents granted in the first six months of 2025. The patent is Titled “Substitued Naphthalene Di